Cholesterol Conversations
✓

Cholesterol Conversations

OVER DEZE PODCAST 🔗

Statin therapy is the first-line pharmacologic treatment for lowering low-density lipoprotein cholesterol (LDL-C) and reducing atherosclerotic cardiovascular disease (ASCVD) risk. However, evidence-based and guideline-recommended therapies continue to be underutilized — even among the highest risk patients. More education is needed to address gaps in ASCVD care, particularly among patients who cannot reach their LDL-C goals with statin therapy alone.
VLN is pleased to launch Cholesterol Conversations, a limited-series podcast discussing the latest guidance on ASCVD management and available treatment options for optimal LDL-C lowering. New data on the efficacy of novel agents and combination therapy is also highlighted.
Geneeskunde
Onderwijs
Geneeskunde
Gezondheid en fitness
Hosts:
Frequentie bijwerken:
every 439 days
Gemiddelde audiolengte:
24 minutes
Gastinterviews
Heeft sponsors
Engels
Verenigde Staten
4 afleveringen
sinds 21 februari 2023
episodic
GebruikAPIom deze podcast op te halen inJSON

IN DEZE PODCAST 🔗

Bewerk deze tags

MEEST RECENTE AFLEVERING 🔗

Now What? Putting the 2026 Dyslipidemia Guidelines into Practice

Now What? Putting the 2026 Dyslipidemia Guidelines into Practice

Your patient's LDL-C is still above goal. What should you do next? Dr. Heather Johnson and Professor Viet Le put the 2026 dyslipidemia guidelines into clinical context and discuss how to use PREVENT-ASCVD, lipoprotein(a), and other risk markers to tailor treatment, set LDL goals, and determine when…
00:24:48
DELEN
OPSLAAN

OUDE AFLEVERINGEN ZOEKEN

Zoek naar eerdere afleveringen van Cholesterol Conversations.
Sluit deze zoekbalk in op uw website

VORIGE AFLEVERINGEN

Mastering LDL Management in 2025

Mastering LDL Management in 2025

· transcriptie
In this episode of Cholesterol Conversations, host Dr. Heather Johnson, Director of Preventive Cardiology for Women's Services at the Christine E. Lynn Women's Health & Wellness Institute of Baptist Health South Florida, sits down with Dr. Viet T. Le, Associate Professor of Research and Co-Dire…
00:29:44
DELEN
OPSLAAN
How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

How Do We Get There from Here: Partnering with Patients to Achieve LDL Goals

In this episode of Cholesterol Conversations, Drs. Marc Bonaca, Pam Taub, and Heather Johnson discuss how multiagent therapy can improve the provision of care in the real world. Covered topics include new data from the 2023 ACC Scientific Sessions on the efficacy of novel agents and the role of com…
00:19:16
DELEN
OPSLAAN
ASCVD Management: Making the Case for Nonstatin Therapies

ASCVD Management: Making the Case for Nonstatin Therapies

In this episode of Cholesterol Conversations, join Drs. Neha Pagidipati, Christie Ballantyne, and Gregory Piazza for a roundtable discussion that addresses recent guidance on ASCVD management, current gaps in ASCVD care, patient barriers to LDL-C lowering, and nonstatin therapies to consider for pa…
00:21:25
DELEN
OPSLAAN
Je hebt alle afleveringen van deze podcast gezien
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van Vasculearn Network, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
PODCAST-ZOEKMACHINE
U kunt onze website gebruiken om3,822,636podcasts en195,573,377afleveringen te zoeken op mensen, plaatsen of onderwerpen.
Investeren in kennis levert het beste rendement op, daarom luister ik naar podcasts.  ‐ Benjamin "Llamacorn" Franklin

AANBEVELINGEN

Gebruik API om deze podcast op te halen